Effect of Shatavari And Dadima In Abnormal Menstrual Bleeding In Adolescent Girls.

An Open Label Randomized Control Trial To Evaluate The Efficacy Of Dadima And Shatavari Formulation In The Management Of Abnormal Uterine Bleeding In Adolescent Girls.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/041315

Enrollment

100

Registered

2022-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E288- Other ovarian dysfunction

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Girls between 12-19 years 2.After one year of menarche 3.Having complaints of abnormal uterine bleeding : â?? irregular or scanty or excessive bleeding and/or having inter menstrual bleeding or spotting.

Exclusion criteria

Exclusion criteria: 1. Having other systemic diseases, severe anemia, congenital anomalies 2. Severe malnourishment 3. Excessive bleeding during menses causing hemodynamic instability and worsening the general condition. 4. Participant who misses 2 follow up. 5. Participant willing to discontinue the treatment.

Design outcomes

Primary

Measure	Time frame
menstruation regulates or not monthly cycle 4-5 days after 28 to 30 days with normal flow according to PBAC(pictorial blood loss analysis chart) scoring for uterine bleeding before and afterTimepoint: partcipant will be assessed at baseline ,after 1st month,2nd month and 3rd month for menstrual pattern	—

Secondary

Measure	Time frame
haemoglobin percentage by measuring on haemoglobinometerTimepoint: baseline and after 3 months	—

Countries

India

Contacts

Public ContactAshwini Narayan Karandikar

Dr D Y Patil College of Ayurved and Research Centre pimpri pune]

neetamahesekar19@gmail.com9553965891

Outcome results